HAZLET, N.J. - June 10, 2026 - PRLog -- In this symposium, cardiac amyloidosis experts (Dr. Ahmad Masri, Dr. Ronald Witteles and Dr. Marcus Urey) will identify red flags that should raise suspicion for ATTR-CM and explain a practical algorithm to make an accurate and early diagnosis. Best use of guideline-recommended medical therapy (GDMT) for HF in ATTR-CM will be described, and clinical evidence with disease-modifying ATTR-CM therapies interpreted. A case-based discussion on optimal management of ATTR-CM will address issues related to recognition, diagnosis, and treatment.
Click here for more information
CHAIR
Marcus Anthony Urey, MD
Associate Professor of Medicine
UC San Diego Health
San Diego, California
FACULTY
Ahmad Masri, MD, MS
Associate Professor of Medicine
Oregon Health and Sciences University
Portland, Oregon
Ronald Witteles, MD
Professor of Medicine (Cardiovascular Medicine)
Stanford University School of Medicine
Stanford, California
Educational Objectives
■ Identify clinical clues that suggest the possibility for an ATTR-CM diagnosis.
■ Explain key steps in the diagnostic algorithm for ATTR-CM.
■ Describe the clinical evidence for ATTR-CM disease-modifying therapies, best adjustments of HF GDMT in patients with ATTR-CM, and novel therapies in development.
Target Audience
This educational activity is intended for cardiovascular clinicians.
Accreditation and Credit Designation Statements
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Photos: (Click photo to enlarge)
Source: CMEPlanet
Read Full Story - 2026 SDHF CME Symposium - Best Practices for Screening, Diagnosing and Treating Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | More news from this source
Press release distribution by PRLog
